Glucagon like peptide-1 and its receptor agonists: Their roles in management of Type 2 diabetes mellitus

Ankit Gupta, Herbert F. Jelinek, Hayder Al-Aubaidy

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

This study summarizes major work which investigated the roles of glucagon like peptide-1 (GLP-1) and its receptor (GLP-1R); the use of GLP-1-R agonists and dipeptidyl peptidase 4 inhibitor in the management of type 2 diabetes mellitus. It focuses on the recent therapeutic development which has occurred in this field, and also discusses the potential treatments which can be discovered and implemented in the near future to design an effective therapy for type 2 diabetes mellitus.
Original languageEnglish
Pages (from-to)225-230
Number of pages5
JournalDiabetes and Metabolic Syndrome: Clinical Research and Reviews
Volume11
Issue number3
Early online date15 Sep 2016
DOIs
Publication statusPublished - 2017

Fingerprint Dive into the research topics of 'Glucagon like peptide-1 and its receptor agonists: Their roles in management of Type 2 diabetes mellitus'. Together they form a unique fingerprint.

  • Cite this